Sort
17,288 grants matching “multiple sclerosis”
Effectiveness of VBP15, a dissociative steroidal analogue, on chronic inflammation in a mouse model of multiple sclerosis
$253,802Jesse Damsker · Reveragen Biopharma, Inc. · R41 · FY2016 · AI
RILUZOLE MOA: TARGETS FOR IMPROVED NEUROPROTECTIVE DRUGS
$253,798Cambria Biosciences, Llc · R43 · FY2004 · NS
Expression and Function of SOCS Proteins in Glial Cells
$253,750Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2008 · NS
OLIGODENDROCYTE ONTOGENY AND DIFFERENTIATION
$253,750University Of Connecticut Sch Of Med/Dnt · R01 · FY2004 · NS
OLIGODENDROCYTE ONTOGENY AND DIFFERENTIATION
$253,750University Of Connecticut Sch Of Med/Dnt · R01 · FY2003 · NS
OLIGODENDROCYTE ONTOGENY AND DIFFERENTIATION
$253,750University Of Connecticut Sch Of Med/Dnt · R01 · FY2005 · NS
Kv1.3 channels: functional biomarker and therapeutic target for Type-1 Diabetes
$253,719George Kanianthara Chandy · University Of California-Irvine · R21 · FY2006 · DK
Mononuclear phagocytes, immunity, and neural progenitor cells
$253,568Jialin Charles Zheng · University Of Nebraska Medical Center · P01 · FY2009 · NS
Genetic loci predisposing to multiple sclerosis (MS)
$253,531University Of California Los Angeles · R01 · FY2002 · NS
Genetic loci predisposing to multiple sclerosis (MS)
$253,531University Of California Los Angeles · R01 · FY2003 · NS
Genetically modified HSC-HPC for management of aggressive demyelinating diseases
$253,500Jack L Strominger · Harvard University · R21 · FY2016 · AI
Dynamical DTI: A method for time-resolved in vivo diffusion tensor imaging
$253,500Eric Edward Sigmund · New York University School Of Medicine · R21 · FY2010 · EB
Alu dsRNAs as adjuvants for influenza vaccines
$253,428Thomas M. Aune · Vanderbilt University Medical Center · R21 · FY2023 · AI
Producing micturition by combined afferent and effernet electrical stimulation
$253,380Kenneth J Gustafson · Case Western Reserve University · R01 · FY2007 · DK
Project 3 - Filippakis
$253,362Charilaos Filippakis · University Of New England · P20 · FY2024 · GM
Project 3 - Filippakis
$253,360Charilaos Filippakis · University Of New England · P20 · FY2025 · GM
High-Impact Trials Center: Collaborative Opportunities Component
$253,078Gary R Cutter · University Of Alabama At Birmingham · P2C · FY2017 · HD
Identification of Novel integrin antagonists
$253,051M. Amin Arnaout · Massachusetts General Hospital · R21 · FY2013 · DK
Vitamin D and the Immune System
$253,000Sylvia S Christakos · Univ Of Med/Dent Of Nj-Nj Medical School · R21 · FY2011 · AI
Biological Targets from Oxetane Templates
$252,914Amy R. Howell · University Of Connecticut Storrs · R01 · FY2006 · AI
Research Training in Rehabilitation for Brain Injury and Neurological Disability
$252,871Michael Van Doren Johnston · Hugo W. Moser Res Inst Kennedy Krieger · T32 · FY2009 · HD
Gene Therapeutic Approach for Tolerance Induction
$252,860David William Scott · University Of Maryland Baltimore · R01 · FY2010 · AI
OLIGODENDROCYTE ONTOGENY AND DIFFERENTIATION
$252,730University Of Connecticut Sch Of Med/Dnt · R01 · FY2002 · NS
The regulation of myeloid cell development and mobilization during autoimmune dem
$252,626Benjamin Matthew Segal · University Of Michigan At Ann Arbor · R01 · FY2014 · NS
MRI: Acquisition of a 3D Printer for Studying Biofluids and Biomechanics
$252,542Tao Xing · Regents Of The University Of Idaho · · FY2020 · ENG